• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞角蛋白19在滤泡性腺瘤、恶性潜能不确定的高分化肿瘤(WDT-UMP)及乳头状癌滤泡变体中的差异表达。

Differential expression of CK 19 in follicular adenoma, well-differentiated tumour of uncertain malignant potential (WDT-UMP) and follicular variant of papillary carcinoma.

作者信息

Bukhari Uzma, Sadiq Saleem, Kehar Shanaz Imdad

机构信息

Pathology Department, Muhammad Medical College, Mirpurkhas.

出版信息

J Pak Med Assoc. 2009 Jan;59(1):15-8.

PMID:19213370
Abstract

OBJECTIVE

To see the expression of cytokeratin 19, a proven helpful marker for the differential diagnosis of neoplastic follicular patterned lesions of thyroid.

METHODS

This was a retrospective study carried out in the Department of Pathology, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre, Karachi from 2000 to 2005. The haematoxylin and eosin (H&E) stained sections were reviewed and the cases were classified according to already published criteria. On the basis of the recent recommendations by Chemobyl Pathologists Group, encapsulated follicular patterned lesions with questionable nuclear changes were categorized as well - differentiated tumours of uncertain malignant potential (WDT-UMP). Formalin fixed paraffin embedded tissues of follicular adenoma, WDT-UMP and follicular variant of papillary carcinoma were obtained for CK 19 immunostaining.

RESULTS

All (16) cases of follicular adenoma were negative for CK19. In a total of 35 cases of WDT- UMP, 10 cases scored 3+ positive for CK19, 15 were 2+ positive and remaining 10 cases were 1+ positive. There were 43 cases of follicular variant of papillary carcinoma with 4+ CK 19 positivity, 14 were 3+ positive and 3 were 2+ positive.

CONCLUSION

CK19 is a good and useful diagnostic marker for differential diagnosis of follicular adenoma, WDT-UMP and follicular variant of papillary carcinoma. The recommendations by Chornobyl Pathologists Group need to be adopted and the cases of WDT-UMP require strict follow-up.

摘要

目的

观察细胞角蛋白19的表达情况,其是甲状腺肿瘤性滤泡样病变鉴别诊断中已证实的有用标志物。

方法

这是一项回顾性研究,于2000年至2005年在卡拉奇真纳研究生医学中心基础医学研究所病理科开展。对苏木精和伊红(H&E)染色切片进行复查,并根据已发表的标准对病例进行分类。根据切尔诺贝利病理学家小组最近的建议,将具有可疑核变化的包膜性滤泡样病变归类为恶性潜能不确定的高分化肿瘤(WDT-UMP)。获取滤泡性腺瘤、WDT-UMP和乳头状癌滤泡变体的福尔马林固定石蜡包埋组织进行CK 19免疫染色。

结果

所有16例滤泡性腺瘤病例的CK19均为阴性。在总共35例WDT-UMP病例中,10例CK19评分为3+阳性,15例为2+阳性,其余10例为1+阳性。有43例乳头状癌滤泡变体病例,4+ CK 19阳性,14例为3+阳性,3例为2+阳性。

结论

CK19是滤泡性腺瘤、WDT-UMP和乳头状癌滤泡变体鉴别诊断的良好且有用的诊断标志物。需要采用切尔诺贝利病理学家小组的建议,并且WDT-UMP病例需要严格随访。

相似文献

1
Differential expression of CK 19 in follicular adenoma, well-differentiated tumour of uncertain malignant potential (WDT-UMP) and follicular variant of papillary carcinoma.细胞角蛋白19在滤泡性腺瘤、恶性潜能不确定的高分化肿瘤(WDT-UMP)及乳头状癌滤泡变体中的差异表达。
J Pak Med Assoc. 2009 Jan;59(1):15-8.
2
Diagnostic criteria of well differentiated thyroid tumor of uncertain malignant potential; a histomorphological and immunohistochemical appraisal.具有不确定恶性潜能的高分化甲状腺肿瘤的诊断标准:组织形态学和免疫组化评估
J Egypt Natl Canc Inst. 2015 Jun;27(2):59-67. doi: 10.1016/j.jnci.2015.02.003. Epub 2015 Mar 21.
3
Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.细胞周期蛋白D1在恶性潜能不确定的高分化甲状腺肿瘤中的表达
Diagn Pathol. 2015 Apr 18;10:32. doi: 10.1186/s13000-015-0262-8.
4
Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.CD56和E-钙黏蛋白表达在甲状腺乳头状癌与疑似甲状腺滤泡样病变鉴别诊断中的作用:E-钙黏蛋白的预后重要性
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3670-80. eCollection 2015.
5
Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.具有可疑核改变的包裹性滤泡状甲状腺肿瘤,所谓的低分化肿瘤,恶性潜能不确定:形态学、免疫组织化学和分子评估。
Cancer Sci. 2011 Jan;102(1):288-94. doi: 10.1111/j.1349-7006.2010.01769.x. Epub 2010 Nov 10.
6
Immunohistochemical and morphometrical evaluation of well-differentiated thyroid tumor of uncertain malignant potential.具有不确定恶性潜能的高分化甲状腺肿瘤的免疫组织化学和形态计量学评估
Indian J Pathol Microbiol. 2019 Jan-Mar;62(1):17-23. doi: 10.4103/IJPM.IJPM_199_18.
7
Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP.低度恶性潜能肿瘤的细胞学特征:不明确的细胞学和 WDT-UMP。
Endocr J. 2012;59(6):483-7. doi: 10.1507/endocrj.ej11-0261. Epub 2012 Apr 7.
8
Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?微 RNA 特征能否区分具有不确定恶性潜能的甲状腺肿瘤和其他分化良好的甲状腺肿瘤?
Endocr Relat Cancer. 2011 Sep 13;18(5):579-94. doi: 10.1530/ERC-10-0283. Print 2011 Oct.
9
Thyroid tumors of uncertain malignant potential: morphologic and imunohistochemical analysis of 29 cases.恶性潜能不确定的甲状腺肿瘤:29例的形态学和免疫组织化学分析
Pathol Res Pract. 2015 Apr;211(4):320-5. doi: 10.1016/j.prp.2014.12.005. Epub 2014 Dec 22.
10
How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.甲状腺结节患者管理中如何处理临界性/前驱性甲状腺肿瘤。
Gland Surg. 2018 Aug;7(Suppl 1):S8-S18. doi: 10.21037/gs.2017.08.02.

引用本文的文献

1
Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.应用细胞周期蛋白 D1 免疫染色和基因组分析的细胞学筛查系统对甲状腺结节诊断的临床影响。
BMC Cancer. 2019 Mar 18;19(1):245. doi: 10.1186/s12885-019-5452-4.
2
Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology.对因细针穿刺细胞学检查诊断为甲状腺乳头状癌而行甲状腺切除术的患者进行细胞病理学检查,但后来通过组织病理学检查发现为良性肿瘤。
Surg Today. 2013 Jun;43(6):632-7. doi: 10.1007/s00595-012-0362-y. Epub 2012 Oct 18.
3
Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.
具有可疑核改变的包裹性滤泡状甲状腺肿瘤,所谓的低分化肿瘤,恶性潜能不确定:形态学、免疫组织化学和分子评估。
Cancer Sci. 2011 Jan;102(1):288-94. doi: 10.1111/j.1349-7006.2010.01769.x. Epub 2010 Nov 10.